Last --
Change Today 0.00 / 0.00%
Volume 0.0
2160 On Other Exchanges
Symbol
Exchange
2160 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

gni group ltd (2160) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for GNI GROUP LTD (2160)

Related News

No related news articles were found.

gni group ltd (2160) Related Businessweek News

No Related Businessweek News Found

gni group ltd (2160) Details

GNI Group Ltd., a clinical-stage bio-pharmaceutical company, engages in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases in Asia, primarily in China and Japan. Its product candidates include F647, an anti-inflammatory small-molecule compound, which has completed Phase II clinical trials for the treatment of radiation-induced pulmonary inflammation and idiopathic pulmonary fibrosis; F351, a non-steroid anti-fibrosis small-molecule drug that is in Phase Ib trial for the treatment of liver fibrosis/cirrhosis and kidney fibrosis; and F573, a di-peptide small-molecule compound for acute liver failure. The company was formerly known as GNI Ltd. and changed its name to GNI Group Ltd. in June, 2011. GNI Group Ltd. was incorporated in 2001 and is headquartered in Tokyo, Japan.

123 Employees
Last Reported Date: 03/28/14
Founded in 2001

gni group ltd (2160) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

gni group ltd (2160) Key Developments

GNI Group Ltd., Annual General Meeting, Mar 27, 2014

GNI Group Ltd., Annual General Meeting, Mar 27, 2014.

GNI Group Ltd. to Report Q3, 2013 Results on Nov 14, 2013

GNI Group Ltd. announced that they will report Q3, 2013 results on Nov 14, 2013

GNI Group Ltd. to Report Q2, 2013 Results on Aug 14, 2013

GNI Group Ltd. announced that they will report Q2, 2013 results on Aug 14, 2013

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
2160:JP ¥313.00 JPY +5.00

2160 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 2160.
View Industry Companies
 

Industry Analysis

2160

Industry Average

Valuation 2160 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 186.4x
Price/Book 12.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 170.1x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GNI GROUP LTD, please visit www.gnipharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.